Literature DB >> 22474312

Medical therapy for the patient with obesity.

George A Bray1, Donna H Ryan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22474312     DOI： 10.1161/CIRCULATIONAHA.111.026567

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  20 in total

1.  Obesity and the Cardiorenal Metabolic Syndrome: Therapeutic Modalities and Their Efficacy in Improving Cardiovascular and Renal Risk Factors.

Authors:  Ankur Jindal; Stephen Brietzke; James R Sowers
Journal:  Cardiorenal Med       Date:  2012-11-24       Impact factor: 2.041

Review 2.  New tools for weight-loss therapy enable a more robust medical model for obesity treatment: rationale for a complications-centric approach.

Authors:  W Timothy Garvey
Journal:  Endocr Pract       Date:  2013 Sep-Oct       Impact factor: 3.443

Review 3.  The Science of Obesity Management: An Endocrine Society Scientific Statement.

Authors:  George A Bray; William E Heisel; Ashkan Afshin; Michael D Jensen; William H Dietz; Michael Long; Robert F Kushner; Stephen R Daniels; Thomas A Wadden; Adam G Tsai; Frank B Hu; John M Jakicic; Donna H Ryan; Bruce M Wolfe; Thomas H Inge
Journal:  Endocr Rev       Date:  2018-04-01       Impact factor: 19.871

Review 4.  Anti-hypertensive drug treatment of patients with and the metabolic syndrome and obesity: a review of evidence, meta-analysis, post hoc and guidelines publications.

Authors:  Jonathan G Owen; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2015-06       Impact factor: 5.369

5.  American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary.

Authors:  Alan J Garber; Martin J Abrahamson; Joshua I Barzilay; Lawrence Blonde; Zachary T Bloomgarden; Michael A Bush; Samuel Dagogo-Jack; Michael B Davidson; Daniel Einhorn; W Timothy Garvey; George Grunberger; Yehuda Handelsman; Irl B Hirsch; Paul S Jellinger; Janet B McGill; Jeffrey I Mechanick; Paul D Rosenblit; Guillermo E Umpierrez; Michael H Davidson
Journal:  Endocr Pract       Date:  2013 May-Jun       Impact factor: 3.443

6.  Enhanced leptin sensitivity, reduced adiposity, and improved glucose homeostasis in mice lacking exchange protein directly activated by cyclic AMP isoform 1.

Authors:  Jingbo Yan; Fang C Mei; Hongqiang Cheng; Dieu Hung Lao; Yaohua Hu; Jingna Wei; Igor Patrikeev; Dapeng Hao; Sonja J Stutz; Kelly T Dineley; Massoud Motamedi; Jonathan D Hommel; Kathryn A Cunningham; Ju Chen; Xiaodong Cheng
Journal:  Mol Cell Biol       Date:  2012-12-21       Impact factor: 4.272

Review 7.  New options for the treatment of obesity and type 2 diabetes mellitus (narrative review).

Authors:  Robert R Henry; Robert Chilton; W Timothy Garvey
Journal:  J Diabetes Complications       Date:  2013-05-28       Impact factor: 2.852

Review 8.  Managing obesity in primary care practice: a narrative review.

Authors:  Raymond Carvajal; Thomas A Wadden; Adam G Tsai; Katherine Peck; Caroline H Moran
Journal:  Ann N Y Acad Sci       Date:  2013-01-16       Impact factor: 5.691

Review 9.  Phentermine and topiramate extended-release: a new treatment for obesity and its role in a complications-centric approach to obesity medical management.

Authors:  William Timothy Garvey
Journal:  Expert Opin Drug Saf       Date:  2013-06-06       Impact factor: 4.250

10.  Early effects of a hypocaloric, Mediterranean diet on laboratory parameters in obese individuals.

Authors:  Marta Greco; Eusebio Chiefari; Tiziana Montalcini; Francesca Accattato; Francesco S Costanzo; Arturo Pujia; Daniela Foti; Antonio Brunetti; Elio Gulletta
Journal:  Mediators Inflamm       Date:  2014-03-04       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.